NEW DELHI — The price of commonly used diabetes drug empagliflozin has been slashed by almost one-tenth, with the entry of its generic versions in the market. Developed by German pharma giant Boehringer Ingelheim (BI) empagliflozin, it is sold under the name Jardiance. It is an oral medication that helps control blood sugar in patients […]
NEW DELHI — WHO Regional Director for South-East Asia Saima Wazed Thursday said more than 60 per cent of people with diabetes in the region are unaware of it and stressed the need for awareness about the condition through campaigns aimed at a healthy lifestyle. She said the care services need to be equitable, comprehensive, […]
NEW DELHI — The overall prevalence of diabetes in the Jammu region is 18.9 per cent, with an alarming 26.5 per cent in urban areas and 14.5 per cent in rural areas, an Indian Council of Medical Research (ICMR)-led study revealed on Sunday. Additionally, 10.8 per cent of the Jammu population is affected by pre-diabetes, […]
